MOUNTAIN VIEW, Calif., Oct. 28, 2019 /PRNewswire-PRWeb/ — NowRx today announced record results for its on-demand, same-day, free delivery pharmacies that are disrupting the $330bn pharmacy industry, with the addition of a record number of new customers in the first half of 2019. The number of new NowRx customers has increased 250% since 2017.

Company revenues also reflect the traction of NowRx’s business, growing tenfold versus its first year of operation.(1) And, NowRx has a 90% satisfaction rating on over 100,000 prescriptions for 18,000 customers – from more than 4,500 physicians. Almost all of NowRx’s growth has resulted from word of mouth, versus marketing efforts by the Company. The Company is also setting fundraising records with its recently announced third crowd-funding round which had one of the fastest ramp-ups in SeedInvest’s history.

NowRx leverages a combination of cutting-edge, proprietary pharma-technology and free, personalized, same-day, door-to-door delivery to create a more efficient, more accurate and more consumer-friendly, time-saving pharmacy experience.

“Our momentum with consumers is directly related to the powerful appeal of our simple no-hassle, same-day, free delivery prescription business premise, while our fundraising success and business viability are correlated to the massive efficiencies our AI-driven robotics technology generates,” said Cary Breese, CEO of NowRx. “In addition to our overall growth numbers, we have experienced record prescription delivery numbers every week for the past three weeks, telling us clearly that the time has come for the pharmacy space to join the on-demand economy – and stop making people wait in line for their medications. I am proud that NowRx is leading that charge.”

NowRx recently expanded from its flagship Mountain View location into San Jose, CA — with further California cities on deck in 2019, and national expansion slated for 2020.

Click here for a video about NowRx and footage of pharma-efficiency fulfillment technology at work.

This Company’s profile and accompanying offering materials may contain forward-looking statements and information relating to, among other things, the Company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events based on information currently available and are subject to risks and uncertainties that could cause the Company’s actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they are meant for illustrative purposes and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. The Company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.

About NowRx
NowRx is an on-demand pharmacy, founded with the goal of developing software, artificial intelligence, robotics, and logistics to create the most convenient retail pharmacy service available, focused on same-day, free delivery for prescription and OTC medications, thereby eliminating the need to visit a pharmacy. Dedicated to promoting better health and wellness through a quicker, easier, more reliable way to access – and adhere to – prescription medications, NowRx hand-delivers all available prescription medications door-to-door, on the same day, through its fleet of friendly, trained drivers. Using NowRx’s proprietary pharma-efficiency technology, NowRx’s team of pharmacists fill prescriptions at its locally-based, state-of-the-art, and fully-licensed pharmacies. With NowRx, consumers can reach their pharmacist on the second ring or instantly through video chat and will never, ever waste time in pharmacy waiting lines again. Learn more at http://www.nowrx.com

NowRx Media Contacts:
mWEBB Communications
Melanie Webber, 424.603.4340 / melanie@mwebbcom.com
Angela Jacobson, 714.454.8776 / angela@mwebbcom.com

(1) 2019 Run Rate based on July 2019 Revenue versus 2016 total revenue

SOURCE NowRx